These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 20116705

  • 1. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A, Bartold M, Sambrook P, Hawker P.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 3. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 4. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 5. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [Abstract] [Full Text] [Related]

  • 6. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R, Need A, Hughes T, Goss A.
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of implant failures in patients with a history of oral bisphosphonate therapy.
    Martin DC, O'Ryan FS, Indresano AT, Bogdanos P, Wang B, Hui RL, Lo JC.
    J Oral Maxillofac Surg; 2010 Mar; 68(3):508-14. PubMed ID: 20171469
    [Abstract] [Full Text] [Related]

  • 8. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER, Basile JD.
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [Abstract] [Full Text] [Related]

  • 9. Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery: a case report and literature review.
    Bedogni A, Bettini G, Totola A, Saia G, Nocini PF.
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1662-6. PubMed ID: 20561470
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
    McLeod NM, Davies BJ, Brennan PA.
    Br Dent J; 2007 Dec 08; 203(11):641-4. PubMed ID: 18065983
    [Abstract] [Full Text] [Related]

  • 11. Oral bisphosphonates and dental implants.
    McLeod NM.
    J Oral Maxillofac Surg; 2009 Jun 08; 67(6):1355. PubMed ID: 19446233
    [No Abstract] [Full Text] [Related]

  • 12. Bisphosphonates and bisphosphonate induced osteonecrosis.
    Sawatari Y, Marx RE.
    Oral Maxillofac Surg Clin North Am; 2007 Nov 08; 19(4):487-98, v-vi. PubMed ID: 18088900
    [Abstract] [Full Text] [Related]

  • 13. Safety of oral bisphosphonates: controlled studies on alveolar bone.
    Jeffcoat MK.
    Int J Oral Maxillofac Implants; 2006 Nov 08; 21(3):349-53. PubMed ID: 16796276
    [Abstract] [Full Text] [Related]

  • 14. [Bisphosphonate-associated osteonecrosis of the jaws 1].
    Allard RH, Lips P, Eekhoff EM, van Merkesteyn JP, van der Waal I.
    Ned Tijdschr Tandheelkd; 2007 Oct 08; 114(10):423-7. PubMed ID: 17972610
    [Abstract] [Full Text] [Related]

  • 15. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb 08; 107(2):e1-7. PubMed ID: 19071040
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonates and dental implants: current problems.
    Flichy-Fernández AJ, Balaguer-Martínez J, Peñarrocha-Diago M, Bagán JV.
    Med Oral Patol Oral Cir Bucal; 2009 Jul 01; 14(7):E355-60. PubMed ID: 19561566
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonate therapy and dental treatment.
    Phillips G.
    J Indiana Dent Assoc; 2009 Jul 01; 86(4):4-8. PubMed ID: 18363257
    [No Abstract] [Full Text] [Related]

  • 18. Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
    Brooks JK, Gilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun 01; 103(6):780-6. PubMed ID: 17223592
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A, Payne AG, Zafar S.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep 01; 108(3):e1-8. PubMed ID: 19570696
    [Abstract] [Full Text] [Related]

  • 20. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
    Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A.
    J Periodontol; 2007 Sep 01; 78(9):1664-9. PubMed ID: 17760533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.